352 related articles for article (PubMed ID: 17724495)
1. A live attenuated human rotavirus vaccine.
Bernstein DI
Drugs Today (Barc); 2007 May; 43(5):281-91. PubMed ID: 17724495
[TBL] [Abstract][Full Text] [Related]
2. Live attenuated human rotavirus vaccine, Rotarix.
Bernstein DI
Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
[TBL] [Abstract][Full Text] [Related]
3. Update on Rotarix: an oral human rotavirus vaccine.
O'Ryan M; Linhares AC
Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
[TBL] [Abstract][Full Text] [Related]
4. Rotarix (RIX4414): an oral human rotavirus vaccine.
O'Ryan M
Expert Rev Vaccines; 2007 Feb; 6(1):11-9. PubMed ID: 17280473
[TBL] [Abstract][Full Text] [Related]
5. Rotavirus vaccines.
Vesikari T
Scand J Infect Dis; 2008; 40(9):691-5. PubMed ID: 19086243
[TBL] [Abstract][Full Text] [Related]
6. A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.
Nakagomi T; Nakagomi O
Expert Opin Biol Ther; 2009 Aug; 9(8):1073-86. PubMed ID: 19591630
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus vaccine RIX4414 (Rotarix).
Keating GM
Paediatr Drugs; 2006; 8(6):389-95; discussion 396-7. PubMed ID: 17154645
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.
Nakagomi O; Iturriza-Gomara M; Nakagomi T; Cunliffe NA
Expert Opin Biol Ther; 2013 Nov; 13(11):1613-21. PubMed ID: 24088009
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus vaccines and vaccination in Latin America.
Linhares AC; Bresee JS
Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
[TBL] [Abstract][Full Text] [Related]
10. A short report on highlights of world-wide development of RIX4414: a Latin American experience.
Linhares AC; Ruiz-Palacios GM; Guerrero ML; Salinas B; Perez-Schael I; Clemens SA; Innis B; Yarzabal JP; Vespa G; Cervantes Y; Hardt K; De Vos B
Vaccine; 2006 May; 24(18):3784-5. PubMed ID: 16098636
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials of rotavirus vaccines in Europe.
Vesikari T; Giaquinto C; Huppertz HI
Pediatr Infect Dis J; 2006 Jan; 25(1 Suppl):S42-7. PubMed ID: 16397428
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus vaccine: early introduction in Latin America-risks and benefits.
Pérez-Vargas J; Isa P; López S; Arias CF
Arch Med Res; 2006 Jan; 37(1):1-10. PubMed ID: 16314179
[TBL] [Abstract][Full Text] [Related]
13. Oral live attenuated human rotavirus vaccine (Rotarix™) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children.
Justino MC; Araújo EC; van Doorn LJ; Oliveira CS; Gabbay YB; Mascarenhas JD; Miranda YS; Guerra Sde F; Silva VB; Linhares AC
Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):846-53. PubMed ID: 23147138
[TBL] [Abstract][Full Text] [Related]
14. Rotavirus vaccines: targeting the developing world.
Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
[TBL] [Abstract][Full Text] [Related]
15. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.
Dang DA; Nguyen VT; Vu DT; Nguyen TH; Nguyen DM; Yuhuan W; Baoming J; Nguyen DH; Le TL;
Vaccine; 2012 Apr; 30 Suppl 1():A114-21. PubMed ID: 22520120
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study.
Phua KB; Lim FS; Lau YL; Nelson EA; Huang LM; Quak SH; Lee BW; Teoh YL; Tang H; Boudville I; Oostvogels LC; Suryakiran PV; Smolenov IV; Han HH; Bock HL
Vaccine; 2009 Oct; 27(43):5936-41. PubMed ID: 19679216
[TBL] [Abstract][Full Text] [Related]
17. Rotavirus vaccine AVANT/GlaxoSmithKline.
Jones T
Curr Opin Investig Drugs; 2001 Jul; 2(7):893-5. PubMed ID: 11757786
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of an ideal rotavirus vaccine.
Reisinger KS; Block SL
Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
